Acute Kidney Injury News and Research

RSS
Acute kidney injury (AKI) involves sudden damage to the kidneys or decrease in renal function that occurs over a few hours or days. The severity of the condition can vary from a minor loss of kidney function to kidney failure.
Discovery about inflammation ‘brake’ gene paves way to personalized treatments for kidney disease

Discovery about inflammation ‘brake’ gene paves way to personalized treatments for kidney disease

Certain urine and blood biomarkers can predict risk of developing chronic kidney disease

Certain urine and blood biomarkers can predict risk of developing chronic kidney disease

Machine learning approach to predict cardiac surgery-associated acute kidney injury

Machine learning approach to predict cardiac surgery-associated acute kidney injury

Migraine drug could be a potential treatment for acute kidney injury

Migraine drug could be a potential treatment for acute kidney injury

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Nova Biomedical Launches CE-Marked Nova Max Pro Creatinine/eGFR Meter for Kidney Function Screening

Nova Biomedical Launches CE-Marked Nova Max Pro Creatinine/eGFR Meter for Kidney Function Screening

Team-oriented approach improves the risk of acquiring post-procedural acute kidney injury

Team-oriented approach improves the risk of acquiring post-procedural acute kidney injury

Outpatient clinic visits with a nephrologist associated with lower risk of mortality in patients with acute kidney injury

Outpatient clinic visits with a nephrologist associated with lower risk of mortality in patients with acute kidney injury

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

Study reports that delaying surgery post-COVID-19 reduces the risk of postoperative cardiovascular issues

Study uncovers new immune target to treat atherosclerosis

Study uncovers new immune target to treat atherosclerosis

Surgical risk for patients who’ve had COVID persists longer than previously known

Surgical risk for patients who’ve had COVID persists longer than previously known

Common kidney disease could be treated with existing medicines, new study shows

Common kidney disease could be treated with existing medicines, new study shows

Correlating circulating adipokine levels with COVID-19 severity

Correlating circulating adipokine levels with COVID-19 severity

Researchers develop transgenic mice with the FRET biosensor for in vivo observation of necroptosis

Researchers develop transgenic mice with the FRET biosensor for in vivo observation of necroptosis

High concentrations of oxygen during anesthesia may increase risk of organ injury

High concentrations of oxygen during anesthesia may increase risk of organ injury

Remdesivir appears to make a big difference in Japanese patients with COVID-19

Remdesivir appears to make a big difference in Japanese patients with COVID-19

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Polyphenols in Mediterranean diet may modulate COVID-19 inflammation

Polyphenols in Mediterranean diet may modulate COVID-19 inflammation

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Prevalence and severity of liver enzyme alterations in COVID-19 and association with patient-centered outcomes

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.